Vimta Labs Limited (VIMTALABS) - Total Assets

Latest as of September 2025: Rs5.18 Billion INR ≈ $56.04 Million USD

Based on the latest financial reports, Vimta Labs Limited (VIMTALABS) holds total assets worth Rs5.18 Billion INR (≈ $56.04 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Vimta Labs Limited total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Vimta Labs Limited - Total Assets Trend (2006–2025)

This chart illustrates how Vimta Labs Limited's total assets have evolved over time, based on quarterly financial data. Check VIMTALABS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Vimta Labs Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Vimta Labs Limited's total assets of Rs5.18 Billion consist of 40.3% current assets and 59.7% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs0.00 3.4%
Accounts Receivable Rs1.06 Billion 22.8%
Inventory Rs250.56 Million 5.4%
Property, Plant & Equipment Rs2.62 Billion 56.1%
Intangible Assets Rs64.19 Million 1.4%
Goodwill Rs0.00 0.0%

Asset Composition Trend (2006–2025)

This chart illustrates how Vimta Labs Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see VIMTALABS company net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Vimta Labs Limited's current assets represent 40.3% of total assets in 2025, a decrease from 56.6% in 2006.
  • Cash Position: Cash and equivalents constituted 3.4% of total assets in 2025, down from 4.2% in 2006.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2006.
  • Asset Diversification: The largest asset category is property, plant & equipment at 56.1% of total assets.

Vimta Labs Limited Competitors by Total Assets

Key competitors of Vimta Labs Limited based on total assets are shown below.

Company Country Total Assets
Maccura Biotechnology Co Ltd
SHE:300463
China CN¥7.99 Billion
Chemclin Diagnostics Co. Ltd. A
SHG:688468
China CN¥1.76 Billion
Healius Ltd
AU:HLS
Australia AU$1.77 Billion
Bionet
TWO:1784
Taiwan NT$3.08 Billion
Eurofins-Cerep SA
PA:ALECR
France €89.02 Million
Monash Ivf Group Ltd
AU:MVF
Australia AU$510.21 Million
RHYTHM Biosciences Ltd
AU:RHY
Australia AU$3.10 Million
Bcal Diagnostics Ltd
AU:BDX
Australia AU$7.17 Million

Vimta Labs Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.30 2.22 1.85
Quick Ratio 2.85 1.88 1.57
Cash Ratio 0.85 0.36 0.00
Working Capital Rs1.48 Billion Rs946.40 Million Rs450.42 Million

Vimta Labs Limited - Advanced Valuation Insights

This section examines the relationship between Vimta Labs Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.01
Latest Market Cap to Assets Ratio 0.06
Asset Growth Rate (YoY) 16.6%
Total Assets Rs4.67 Billion
Market Capitalization $288.66 Million USD

Valuation Analysis

Below Book Valuation: The market values Vimta Labs Limited's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Vimta Labs Limited's assets grew by 16.6% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Vimta Labs Limited (2006–2025)

The table below shows the annual total assets of Vimta Labs Limited from 2006 to 2025.

Year Total Assets Change
2025-03-31 Rs4.67 Billion
≈ $50.45 Million
+16.62%
2024-03-31 Rs4.00 Billion
≈ $43.26 Million
+10.41%
2023-03-31 Rs3.62 Billion
≈ $39.18 Million
+17.95%
2022-03-31 Rs3.07 Billion
≈ $33.22 Million
+11.97%
2021-03-31 Rs2.74 Billion
≈ $29.67 Million
+11.63%
2020-03-31 Rs2.46 Billion
≈ $26.58 Million
+3.51%
2019-03-31 Rs2.37 Billion
≈ $25.68 Million
+2.23%
2018-03-31 Rs2.32 Billion
≈ $25.12 Million
+4.79%
2017-03-31 Rs2.22 Billion
≈ $23.97 Million
+26.22%
2016-03-31 Rs1.76 Billion
≈ $18.99 Million
+19.99%
2015-03-31 Rs1.46 Billion
≈ $15.83 Million
-1.80%
2014-03-31 Rs1.49 Billion
≈ $16.12 Million
+3.06%
2013-03-31 Rs1.45 Billion
≈ $15.64 Million
-7.56%
2012-03-31 Rs1.56 Billion
≈ $16.92 Million
-11.39%
2011-03-31 Rs1.77 Billion
≈ $19.09 Million
-2.92%
2010-03-31 Rs1.82 Billion
≈ $19.67 Million
+7.09%
2009-03-31 Rs1.70 Billion
≈ $18.36 Million
-1.59%
2008-03-31 Rs1.73 Billion
≈ $18.66 Million
-0.78%
2007-03-31 Rs1.74 Billion
≈ $18.81 Million
+1.81%
2006-03-31 Rs1.71 Billion
≈ $18.47 Million
--

About Vimta Labs Limited

NSE:VIMTALABS India Diagnostics & Research
Market Cap
$288.66 Million
Rs26.69 Billion INR
Market Cap Rank
#14976 Global
#756 in India
Share Price
Rs598.00
Change (1 day)
+1.09%
52-Week Range
Rs380.70 - Rs877.20
All Time High
Rs1155.00
About

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract researc… Read more